Patent 10918313 was granted and assigned to Dexcom on February, 2021 by the United States Patent and Trademark Office.
The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.